featured
Efficacy and Safety of GLP-1 Receptor Agonists in Familial Partial Lipodystrophy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy
Diabetes Care 2024 Apr 01;47(4)653-659, MC Foss-Freitas, S Imam, A Neidert, AD Gomes, DT Broome, EA OralFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.